Sarepta Therapeutics, Inc. SRPT Manufacturing Related Deposits And Prepaids
Manufacturing Related Deposits And Prepaids at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:ManufacturingRelatedDepositsAndPrepaids.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s manufacturing related deposits and prepaids.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s manufacturing related deposits and prepaids?
- Sarepta Therapeutics, Inc. (SRPT) reported manufacturing related deposits and prepaids of $72.79M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s manufacturing related deposits and prepaids changed year-over-year?
- Sarepta Therapeutics, Inc.'s manufacturing related deposits and prepaids decreased by 64.2% year-over-year, from $203.49M to $72.79M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s manufacturing related deposits and prepaids?
- Over 2 years (2023 to 2025), Sarepta Therapeutics, Inc.'s manufacturing related deposits and prepaids has grown at a 5.4% compound annual growth rate (CAGR), from $102.18M to $113.46M.
- What does manufacturing related deposits and prepaids mean?
- This metric represents advance payments made to third-party manufacturers or suppliers for the procurement of raw materials, components, or production capacity. It reflects the company's commitment to securing supply chain stability and production timelines for its therapeutic products. Monitoring this balance helps investors assess the company's capital tied up in manufacturing operations and potential future production scale.